μ-conotoxin KIIIA derivatives with divergent affinities versus efficacies in blocking voltage-gated sodium channels.
The possibility of independently manipulating the affinity and efficacy of pore-blocking ligands of sodium channels is of interest for the development of new drugs for the treatment of pain. The analgesic mu-conotoxin KIIIA (KIIIA), a 16-residue peptide with three disulfide bridges, is a pore blocker of voltage-gated sodium channels, including neuronal subtype Na(V)1.2 (K(d) = 5 nM). At saturating concentrations, KIIIA incompletely blocks the sodium current of Na(V)1.2, leaving a 5% residual current (rI(Na)). Lys7 is an important residue: the K7A mutation decreases both the efficacy (i.e., increases rI(Na) to 23%) and the affinity of the peptide (K(d) = 115 nM). In this report, various replacements of residue 7 were examined to determine whether affinity and efficacy were inexorably linked. Because of their facile chemical synthesis, KIIIA analogues that had as a core structure the disulfide-depleted KIIIA[C1A,C2U,C9A,C15U] (where U is selenocysteine) or ddKIIIA were used. Analogues ddKIIIA and ddKIIIA[K7X], where X represents one of nine different amino acids, were tested on voltage-clamped Xenopus oocytes expressing rat Na(V)1.2 or Na(V)1.4. Their affinities ranged from 0.01 to 36 muM and rI(Na) values from 2 to 42%, and these two variables appeared to be uncorrelated. Instead, rI(Na) varied inversely with side chain size, and remarkably charge and hydrophobicity appeared to be inconsequential. The ability to manipulate a mu-conopeptide's affinity and efficacy, as well as its capacity to interfere with subsequent tetrodotoxin binding, greatly expands its scope as a reagent for probing sodium channel structure and function and may also lead to the development of mu-conotoxins as safe analgesics.
Zhang
Min-Min
MM
Department of Biology, University of Utah, Salt Lake City, Utah 84112, USA.
Han
Tiffany S
TS
Olivera
Baldomero M
BM
Bulaj
Grzegorz
G
Yoshikami
Doju
D
D000595:Amino Acid Sequence; D019943:Amino Acid Substitution / Q000235:genetics; D000818:Animals; D020916:Conotoxins / Q000138:chemical synthesis / Q000378:metabolism*; D004220:Disulfides / Q000378:metabolism; D007202:Indicators and Reagents; D008969:Molecular Sequence Data; D009124:Muscle Proteins / Q000502:physiology*; D062551:NAV1.2 Voltage-Gated Sodium Channel; D009419:Nerve Tissue Proteins; D009865:Oocytes / Q000378:metabolism; D011485:Protein Binding; D011522:Protons; D051381:Rats; D017279:Selenocysteine / Q000235:genetics; D026941:Sodium Channel Blockers / Q000138:chemical synthesis / Q000378:metabolism*; D015222:Sodium Channels / Q000502:physiology*; D014981:Xenopus
D020916:Conotoxins; D004220:Disulfides; D007202:Indicators and Reagents; D009124:Muscle Proteins; D062551:NAV1.2 Voltage-Gated Sodium Channel; D009419:Nerve Tissue Proteins; D011522:Protons; C568253:Scn2A protein, rat; C466180:Scn4a protein, rat; D026941:Sodium Channel Blockers; D015222:Sodium Channels; D017279:Selenocysteine
Annu Rev Genomics Hum Genet. 2009;10:483-511
19640225
Curr Med Chem. 2004 Dec;11(23):3053-64
15578999
Channels (Austin). 2009 Jan-Feb;3(1):32-8
19221510
Biochem Pharmacol. 2008 Jun 15;75(12):2334-44
18486102
Biophys J. 1998 Dec;75(6):2647-57
9826589
Dev Biol. 1990 Dec;142(2):360-7
2175278
Biochemistry. 2005 May 17;44(19):7259-65
15882064
ChemMedChem. 2009 Mar;4(3):406-14
19107760
Eur J Biochem. 1986 May 15;157(1):169-80
3709531
Anesthesiology. 2007 Feb;106(2):339-45
17264729
Biochemistry. 2009 Feb 17;48(6):1210-9
19170536
J Biol Chem. 2007 Oct 19;282(42):30699-706
17724025
J Nat Prod. 2004 Aug;67(8):1211-5
15332834
J Neurosci. 2006 Dec 13;26(50):12852-60
17167076
Neurol Res. 2009 Apr;31(3):228-33
19040797
J Biol Chem. 1991 Sep 15;266(26):16989-91
1654319
Genome Biol. 2003;4(3):207
12620097
Curr Pharm Des. 2008;14(24):2492-502
18781997
Pharmacol Rev. 2005 Dec;57(4):397-409
16382098
J Am Chem Soc. 2010 Mar 17;132(10):3514-22
20163143
Biochemistry. 2010 Mar 30;49(12):2741-52
20175537
J Biol Chem. 2006 May 19;281(20):14136-43
16500898
Nat Neurosci. 1999 Jun;2(6):541-8
10448219
J Biol Chem. 2007 Mar 16;282(11):8044-51
17237232
J Gen Physiol. 2002 Jan;119(1):45-54
11773237
ACS Med Chem Lett. 2010 May 3;1(4):140-144
20676359
Physiol Rev. 2004 Jan;84(1):41-68
14715910
J Neurosci. 2008 Nov 12;28(46):11768-77
19005038
J Neurobiol. 2004 Oct;61(1):55-71
15362153
Angew Chem Int Ed Engl. 2009;48(12):2221-4
19206132
Biochemistry. 2002 Dec 24;41(51):15388-93
12484778
Expert Opin Ther Targets. 2008 Sep;12(9):1191-203
18694383
J Biol Chem. 1985 Aug 5;260(16):9280-8
2410412
Biochimie. 2000 Sep-Oct;82(9-10):883-92
11086218
Br J Anaesth. 2006 Jun;96(6):761-8
16675510
Proc Natl Acad Sci U S A. 1986 Jul;83(14):5321-5
2425365
Neuron. 1996 Feb;16(2):407-13
8789955